Potential role of calcineurin for brain ischemia and traumatic injury

Progress in Neurobiology

Volumn 58, Issue 1, 1999, Pages 1-30

  Morioka, Motohiro ^b   Hamada, Jun Ichiro ^b   Ushio, Yukitaka ^b   Miyamoto, Eishichi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCIUM; CYCLOSPORIN A; DYNAMIN; GLUTAMATE DECARBOXYLASE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IMMUNOPHILIN; MARCKS PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROGRANIN; NEUROMODULIN; NITRIC OXIDE SYNTHASE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE (CALCIUM,CALMODULIN); TACROLIMUS;

ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CELL DEATH; CENTRAL NERVOUS SYSTEM FUNCTION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; HYPOTHERMIA; HYPOTHESIS; IMMUNOSUPPRESSIVE TREATMENT; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION;

EID: 0032941253     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(98)00073-2     Document Type: Review

References (394)

1. Abe K., Kogure K., Yamamoto H., Imazawa M., Miyamoto K. Mechanisms of arachidonic acid liberation during ischemia in gerbil cerebral cortex. J. Neurochem. 48:1987;503-509.
2. Abe K., Aoki M., Kawagoe J., Yoshida T., Hattori A., Kogure K., Itoyama Y. Ischemic delayed neuronal death. A mitochondrial hypothesis Stroke. 26:1995;1478-1489.
3. Adams J. H., Graham D. I., Murray L. S., Scott G. Diffuse axonal injury due to nonmissile head injury in humans: an analysis of 45 cases. Ann. Neurol. 12:1982;557-563.
4. Aderem A. A., Albert K. A., Keum M. M., Wang J. K., Greengard P., Cohn Z. A. Stimulus-dependent myristoylation of a major substrate for protein kinase C. Nature. 332:1988;362-364.
5. Ahuja S. S., Shrivastav S., Danielpour D., Balow J. E., Boumpas D. T. Regulation of transforming growth factor-β and its receptor by cyclosporin in human T lymphocytes. Transplantation. 60:1995;718-723.
6. Aitken A., Klee C. B., Cohen P. The structure of the B subunit of calcineurin. Eur. J. Biochem. 139:1984;663-671.
7. Albert K. A., Wu W. C., Nairn A. C., Greengard P. Inhibition by calmodulin of calcium/phospholipid-dependent protein phosphorylation. Acad. Sci. USA. 81:1984;3622-3625.
8. Alexander J. H. P., Wakim B. T., Doyle G. S., Walsh K. A., Storm D. R. Identification and characterization of the calmodulin-binding domain of neuromodulin, a neurospecific calmodulin-binding protein. J. Biol. Chem. 263:1988;7544-7549.
9. Ankarcrona M., Dypbukt J. M., Orrenius S., Nicotera P. Calcineurin and mitochondrial function in glutamate-induced neuronal cell death. FEBS Lett. 394:1996;321-324.
10. Apel E. D., Byford M. F., Au D., Walsh K. A., Storm D. R. Identification of the protein kinase C phosphorylation site in neuromodulin. Biochemistry. 29:1990;2330-2335.
11. Arai H., Passonneau J. V., Lust W. D. Energy metabolism in delayed neuronal death of CA1 neurons of the hippocampus following transient ischemia in the gerbil. Metab. Brain Dis. 1:1986;263-268.
12. Arends M. J., Morris R. G., Wyllie A. H. Apoptosis: the role of endnuclease. Am. J. Pathol. 136:1990;593-608.
13. 2+-activated phosphatase in mammalian brain. Trends Neurosci. 12:1989;117-122.
14. 2+/calmodulin-dependent protein kinase II: potential role in neuronal damage. J. Neurochem. 58:1992;1743-1753.
15. Bahler M., Greengard P. Synapsin I bundles F-actin in a phosphorylation-dependent manner. Nature. 326:1987;704-707.
16. Baines A. J., Bennett V. Synapsin I is a microtubule-bundling protein. Nature. 319:1986;145-147.
17. Bao J., Cheung W. Y., Wu J. Y. Brain L-glutamate decarboxylase. Inhibition by phosphorylation and activation by dephosphorylation. J. Biol. Chem. 270:1995;6464-6467.
18. Baudier J., Cole R. D. Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids. J. Biol. Chem. 262:1987;17577-17583.
19. Baudier J., Deloulme J. C., Van Dorsselaer A., Black D., Matthes H. W. D. Purification and characterization of a brain-specific protein kinase C substrate, neurogranin (p17). Identification of a consensus amino acid sequence between neurogranin and neuromodulin (GAP43) that corresponds to the protein kinase C phosphorylation site and the calmodulin-binding domain. J. Biol. Chem. 266:1991;229-237.
20. Baumann G., Geisse S., Sullivan M. Cyclosporin A and FK-506 both affect DNA binding of regulatory nuclear proteins to the human interleukin-2 promoter. New Biol. 3:1991;270-278.
21. Beals C. R., Sheridan C. M., Turck C. W., Gardner P., Crabtree G. R. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science. 275:1997;1930-1933.
22. Bean B. P. Classes of calcium channels in vertebrate cells. An. Rev. Physiol. 51:1989;367-384.
23. Beck T., Wree A., Saucer D. D. Chronic infusion of nerve growth factor does not rescue pyramidal cells after transient forebrain ischemia in the rat. Neurosci. Lett. 135:1992;252-254.
24. Beckman J. S., Carson M., Smith C. D., Koppenol W. H. ALS, SOD and peroxynitrite. Nature. 364:1993;584.
25. Bednar M. M., Raymond S., Mcauliffe T., Lodge P. A., Gross C. E. The role of neutrophils and platelets in a rabbit model of thromboembolic stroke. Stroke. 22:1991;44-50.
26. Begley D. J., Squires L. K., Zlokovic B. V., Mitrovic D. M., Hughes C. C., Revest P. A., Greenwood J. Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A. J. Neurochem. 55:1990;1222-1230.
27. Berchtold M. W., Heizmann C. W., Wilson K. J. Primary structure of parvalbumin from rat skeletal muscle. Eur. J. Biochem. 127:1982;381-389.
28. 2+ in hippocampal neurons. Neuron. 9:1992;285-294.
29. 2+ and stimulus duration-dependent switch for hippocampal gene expression. Cell. 87:1996;1203-1214.
30. Bliss T. V. P., Collingridge G. L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
31. Bliss T. V. P., Lømo T. Long-lasting potentiation of synaptic transmission in the dentate ares of the anesthetized rabbit following stimulation of the perforant path. J. Physiol., Lond. 233:1973;334-356.
32. Blumenthal D. K., Takio K., Hansen R. S., Krebs E. G. Dephosphorylation of cAMP-dependent protein kinase regulatory subunit (type II) by calmodulin-dependent protein phosphatase. Determinants of substrate specificity. J. Biol. Chem. 261:1986;8140-8145.
33. Bodsch W., Takahashi K., Barbier B., Ophoff G., Hossmann K. A. Cerebral proteins and ischemia. Prog. Brain. Res. 63:1985;197-210.
34. Boje K. M., Arora P. K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587:1992;250-256.
35. Bredt D. S., Snyder S. H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl Acad. Sci. USA. 87:1990;682-685.
36. Bredt D. S., Snyder S. H. Nitric oxide: a physiologic messenger molecule. Ann. Rev. Biochem. 63:1994;175-195.
37. Bredt D. S., Ferris C. D., Snyder S. H. Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites. J. Biol. Chem. 267:1992;10976-10981.
38. Brierley, J. B. (1976) Cerebral hypoxia. In: Greenfield's Neuropathology, pp. 43-85. Eds. W. Blackwood and J. A. N. Corsellis. Year Book Medical Publishers, Chicago.
39. Brillantes A. B., Ondrias K., Scott A., Kobrinsky E., Ondrisova E., Moschella M. C., Jayaraman T., Landers M., Ehlrich B. E., Marks A. R. Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell. 77:1994;513-523.
40. Burns R. G., Islam K., Chapman R. The multiple phosphorylation of the microtubule-associated protein MAP2 controls the MAP2 tubulin interaction. Eur. J. Biochem. 141:1984;609-615.
41. Busto R., Dietrich W. D., Globus M. Y., Valdes I., Scheinberg P., Ginsberg M. D. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J. Cereb. Blood Flow Metab. 7:1987;729-738.
42. Busto R., Globus M. Y., Dietrich W. D., Martinez E., Valdes I., Ginsberg M. D. Effect of mild hypothermia on ischemia-induced release of neurotransmitters and free fatty acids in rat brain. Stroke. 20:1989;904-910.
43. Busto R., Globus M. Y., Mearly J. T., Ginsberg M. D. Regional alterations of protein kinase C activity following transient cerebral ischemia: effects of intraischemic brain temperature modulation. J. Neurochem. 63:1994;1095-1103.
44. Butcher S. P., Hanshall D. C., Teramura Y., Iwasaki K., Sharkey J. Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. J. Neurosci. 17:1997;6939-6946.
45. Calalb M. B., Kincaid R. L., Soderling T. R. Phosphorylation of calcineurin: Effect on calmodulin binding Biochem. Biophys. Res. Commun. 172:1990;551-556.
46. 2+ flux. Cell. 83:1995;463-472.
47. Cameron A. M., Steiner J. P., Sabatini D. M., Kaplin A. I., Walensky L. D., Snyder S. H. Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux. Proc. Natl Acad. Sci. USA. 92:1995;1784-1788.
48. Cardell M., Wieloch T. Time course of translocation and inhibition of protein kinase C during complete cerebral ischemia in the rat. J. Neurochem. 61:1993;1308-1314.
49. Carr S. A., Biemann K., Shoji S., Parmelee D. C., Titani K. n-Tetradecanoyl is the NH2-terminal blocking group of the catalytic subunit of cyclic AMP-dependent protein kinase from bovine cardiac muscle. Proc. Natl Acad. Sci. USA. 79:1982;6128-6131.
50. Chad J. E., Eckert R. An enzymatic mechanism for calcium current inactivation in dialysed Helix neurones. J. Physiol. 378:1986;31-51.
51. Chan P. H. Role of oxidants in ischemic brain damage. Stroke. 27:1996;1124-1129.
52. Chan P. H., Fishman B. A., Longarm S., Chu L. Protective effects of liposome-entrapped superoxide dismutase on post-traumatic brain edema. Ann. Neurol. 21:1987;540-547.
53. Chan P. H., Kamii H., Yang G., Gafni J., Epstein C. J., Carlson E., Reola L. Brain infarction is not reduced in SOD-1 transgenic mice after a permanent focal cerebral ischemia. Neuroreport. 5:1993;293-296.
54. Chan P. H., Epstein C. J., Li Y., Huang T. T., Carlson E., Kinouchi H., Yang G., Kamii H., Mikawa S., Kondo T. Transgenic mice and knockout mutants in the study of oxidative stress in brain injury. J. Neurotrauma. 12:1995;815-824.
55. Chang H. Y., Takei K., Sydor A. M., Born T., Rusnak F., Jay D. G. Asymmetric retraction of growth cone filopodia following focal inactivation of calcineurin. Nature. 376:1995;686-690.
56. Chen H., Chopp M., Bodzin G. Neutropenia reduces the volume of cerebral infarct after transient middle cerebral artery occlusion in the rat. Neurosci. Res. Commun. 11:1992;93-99.
57. Chen H., Chopp M., Zhang R. L., Bodzin G., Chen Q., Rusche J. R., Todd R. F., Iii. Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Ann. Neurol. 35:1994;458-463.
58. Chernoff J., Sells M. A., Li H. C. Characterization of phosphotyrosyl-protein phosphatase activity associated with calcineurin. Biochem. Biophys. Res. Commun. 121:1984;141-148.
59. Chesselet M. F., Gonzales C., Lin C. S., Polsky K., Jin B. K. Ischemic damage in the striatum of adult gerbils: relative sparing of somatostatinergic and cholinergic interneurons contrasts with loss of efferent neurons. Exp. Neurol. 110:1990;209-218.
60. Cheung J. Y., Bonventre J. V., Malis C. D., Leaf A. Calcium and ischemic injury. N. Engl. J. Med. 314:1986;1670-1676.
61. Choi D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
62. Choi D. W. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. A. Rev. Neurosci. 13:1990;171-182.
63. Choi D. W. Ischemia-induced neuronal apoptosis. Curr. Opin. Neurobiol. 6:1996;667-672.
64. Chopp M., Zhang R. L., Chen R. L., Li Y., Jiang N., Rusche J. R. Postischemic administration of anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke. 25:1994;869-876.
65. Churn S. B., Taft W. C., Billingsley M. S., Sankaran B., Delorenzo R. J. Global forebrain ischemia induces a post-translational modification of multifunctional calcium- and calmodulin-dependent protein kinase II. J. Neurochem. 59:1992;1221-1232.
66. Churn S. B., Limbrick D., Sombati S., DeLorenzo R. J. Excitotoxic activation of the NMDA receptor results in inhibition of calcium/calmodulin kinase II activity in cultured hippocampal neurons. J. Neurosci. 15:1995;3200-3214.
67. Cimler B. M., Andreasen T. J., Andreasen K. I., Storm D. R. P-57 is a neural specific calmodulin-binding protein. J. Biol. Chem. 260:1985;10784-10788.
68. Clark G. D., Happel L. T., Zorumski C. F., Bazan N. G. Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. Neuron. 9:1992;1211-1216.
69. Clemens J. A., Stephenson D. T., Smalstig E. B., Dixon E. P., Little S. P. Global ischemia activates nuclear factor-κB in forebrain neurons of rats. Stroke. 28:1997;1073-1081.
70. Clipston N. A., Crabtree G. R. Identification of calcineurin as a key signaling enzyme in T-lymphocyte activation. Nature. 357:1992;695-697.
71. Cockerill P. N., Shannon M. F., Bert A. G., Ryan G. R., Vadas M. A. The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. Proc. Natl Acad. Sci. USA. 90:1993;2466-2470.
72. Coggins P. J., Zwiers H. Evidence for a single kinase C-mediated phosphorylation site in rat brain protein B-50. J. Neurochem. 53:1989;1895-1901.
73. Coghlan V. M., Perrino B. A., Howard M., Langeberg L. K., Hicks J. B., Gallatin W. M., Scott J. D. Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science. 267:1995;108-111.
74. Cohen P. Protein phosphorylation and hormone action. Proc. R. Soc. (Lond.). 234:1988;115-144.
75. Colbert C. M., Burger B. S., Levy W. B. Longevity of synaptic depression in the hippocampal dentate gyrus. Brain Res. 571:1992;159-161.
76. Conde M., Andrade J., Bedoya F. J., Santa Maria C., Sobrino F. Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages. Evidence of a direct effect on nitric oxide synthase activity. Immunology. 84:1995;476-481.
77. Crumrine R. C., Dubyak G., LaManna J. C. Decreased protein kinase C activity during cerebral ischemia and after reperfusion in the adult rat. J. Neurochem. 55:1990;2001-2007.
78. Crumrine R. C., Selman W. R., LaManna J. C., Lust W. D. Protein kinase C activity in permanent cerebral ischemia. Mol. Chem. Neuropath. 16:1992;85-93.
79. Curran T., Morgan J. I. Fos: an immediate-early transcription factor in neurons. J. Neurobiol. 26:1995;403-412.
80. 2+/calmodulin-dependent phosphoprotein phosphatases is required for adaptation to pheromone. Mol. Cell. Biol. 12:1992;3460-3469.
81. Cyert M. S., Kunisawa R., Kaim D., Thorner J. Yeast has homologs (CNA1 and CNA2 gene products) of mammalian calcineurin, a calmodulin-regulated phosphoprotein phosphatase. Proc. Natl Acad. Sci. USA. 88:1991;7376-7380.
82. Dalkara T., Moskowitz M. A. The complex role of nitric oxide in the pathophysiology of focal cerebral ischemia. Brain Pathol. 4:1994;49-57.
83. Dawson D. A. Nitric oxide and focal cerebral ischemia: multiplicity of actions and diverse outcome. Cerebrovasc. brain Metab. Rev. 6:1994;299-324.
84. Dawson T. M., Snyder S. H. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J. Neurosci. 14:1994;5147-5159.
85. Dawson T. M., Dawson V. L., Snyder S. H. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol. 32:1992;297-311.
86. Dawson T. M., Steiner J. P., Dawson V. L., Dinerman J. L., Uhl G. R., Snyder S. H. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc. Natl Acad. Sci. USA. 90:1993;9808-9812.
87. Dawson T. M., Steiner J. P., Lyons W. E., Fotuhi M., Blue M., Snyder S. H. The immunophilins, FK506 binding protein and cyclophilin, are discretely localized in the brain. relationship to calcineurin Neuroscience. 62:1994;569-580.
88. Dawson V. L., Dawson T. M., London E. D., Bredt D. S., Snyder S. H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl Acad. Sci. USA. 88:1991;6368-6371.
89. De Camilli P., Harris J. M. Jr, Huttner W. B., Greengard P. Synapsin I (Protein I), a nerve terminal-specific phosphoprotein. II. Its specific association with synaptic vesicles demonstrated by immunocytochemistry in agarose-embedded synaptosomes. J. Cell Biol. 96:1983;1355-1373.
90. De Camilli P., Takei K., McPherson P. S. The function of dynamin in endocytosis. Curr. Biol. 5:1995;559-565.
91. Dekker L. V., DeGraan P. N. E., Oestreicher A. B., Versteeg D. H. G., Gispen W. H. Inhibition of noradrenaline release by antibodies to B-50 (GAP-43). Nature. 342:1989;74-76.
92. Del Zoppo G.J., Schmid-Schönbein G. W., Mori E., Copeland B. R., Chang C. M. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke. 22:1991;1276-1283.
93. Desdouits F., Cohen D., Nairn A. C., Greengard P., Girault J. A. Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase I in vitro and in vivo. J. Biol. Chem. 270:1995;8772-8778.
94. Desdouits F., Siciliano J. C., Greengard P., Girault J. A. Dopamine- and cAMP-regulated phosphoprotein DARPP-32: phosphorylation of Ser-137 by casein kinase I inhibits dephosphorylation of Thr-34 by calcineurin. Proc. Natl Acad. Sci. USA. 92:1995;2682-2685.
95. Deshpande J., Bergstedt K., Linden T., Kalimo H., Wieloch T. Ultrastructural changes in the hippocampal CA1 region following transient cerebral ischemia: evidence against programmed cell death. Exp. Brain Res. 88:1992;91-105.
96. Dienel G. A., Pulsinelli W. A., Duffy T. E. Regional protein synthesis in rat brain following acute hemispheric ischemia. J. Neurochem. 35:1980;1216-1226.
97. Dietrich W. D., Busto R., Alonso O., Globus M. Y. T., Ginsberg M. D. Intraischemic but not postischemic brain hypothermia protects chronically following global forebrain ischemia in rats. J. Cereb. Blood Flow Metab. 13:1993;541-549.
98. Dixon C. E., Lyeth B. G., Povlishock J. T., Findling R. L., Hamm R. J., Marmarou A., Young H. F., Hayes R. L. A fluid-percussion model of experimental brain injury in the rat. J. Neurosurg. 67:1987;110-119.
99. Dixon C. E., Clifton G. L., Lighthall J. W., Yaghmai A. A., Hayes R. L. A controlled cortical impact model of traumatic brain injury in the rat. J. Neurosci. Meth. 39:1991;253-262.
100. Domanska-Janik K., Zalewska T. Effect of brain ischemia on protein kinase C. J. Neurochem. 58:1992;1432-1439.
101. Drake M., Freiberg H., Boris-Möller F., Sakata K., Wieloch T. The immunosuppressant FK506 ameliorates ischaemic damage in the rat brain. Acta Physiol. Scand. 158:1996;155-159.
102. Drewes G., Lichtenberg-Kraag B., Doring F., Mandelkow E. M., Biernat J., Goris J., Doree M., Mandelkow E. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J. 11:1992;2131-2138.
103. Duckrow R. B., LaManna J. C., Rosenthal M., Lavasseur J. E., Patterson J. L. Jr. Oxidative metabolism activity of cerebral cortex after fluid-percussion head injury in the cat. J. Neurosurg. 54:1981;607-614.
104. Durand D. B., Shaw J. P., Bush M. R., Replogle R. E., Belagaje R., Crabtree G. R. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8:1988;1620-1715.
105. Earnest S., Khokhlatchev A., Albanesi J. P., Barylko B. Phosphorylation of dynamin by ERK2 inhibits the dynami-microtubule interaction. FEBS Lett. 396:1996;62-66.
106. Ebihara K., Fukunaga K., Matsumoto K., Shichiri M., Miyamoto E. Cyclosporin A stimulation of glucose-induced insulin secretion in MIN6 cells. Endocrinology. 137:1996;5255-5263.
107. Enan E., Matsumura F. Specific inhibition of calcineurin by type II synthetic pyrethroid insecticides. Biochem. Pharmacol. 43:1992;1777-1784.
108. Endoh M., Maiese K., Wagner J. Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia. Brain Res. 651:1994;92-100.
109. 2+/calmodulin-dependent protein kinase IV; role in transcriptional regulation. J. Biol. Chem. 269:1994;15520-15527.
110. Faden A. I., Demediuk P., Panter S. S., Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science. 244:1989;798-800.
111. 2+/calmodulin. J. Biol. Chem. 272:1997;17038-17044.
112. Flanagan W. M., Corthesy B., Bram R. J., Crabtree G. R. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature. 352:1991;803-807.
113. Fleming L. M., Johnson G. V. Modulation of the phosphorylation state of tau in situ: the roles of calcium and cyclic AMP. Biochem. J. 309:1995;41-47.
114. Frantz B., Nordby E. C., Bren G., Steffan N., Paya C. V., Kincaid R. L., Tocci M. J., O'Keefe S. J., O'Neil E. A. Calcineurin acts in synergy with PMA to inactivate IκB/MAD3, an inhibitor of NF-κB. EMBO J. 13:1994;861-870.
115. Fruman D. A., Burakoff S. J., Bierer B. E. Immunophilins in protein folding and immunosuppression. FASEB J. 8:1994;391-400.
116. 2+ signaling in the brain. J. Neurochem. 64:1995;953-960.
117. Furuta S., Ohta S., Hatakeyama T., Nakamura K., Sakaki S. Recovery of protein synthesis in tolerance-induced hippocampal CA1 neurons after transient forebrain ischemia. Acta Neuropathol. 86:1993;329-336.
118. Garcia J. H., Liu K. F., Yoshida Y., Lian J., Chen S., del Zoppo G.J. Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am. J. Pathol. 144:1994;188-199.
119. Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
120. Geddes J. W., Schwab C., Craddock S., Wilson J. L., Pettigrew L. C. Alteration in τ immunostaining in the rat hippocampus following transient cerebral ischemia. J. Cereb. Blood Flow Metab. 14:1994;554-564.
121. Genestier L., Bonnefoy-Berard N., Rouault J. P., Flacher M., Revillard J. P. Tumor necrosis factor-alpha up-regulates Bcl-2 expression and decreases calcium-dependent apoptosis in human B cell lines. Int. Immunol. 7:1995;533-540.
122. Gennarelli T. A. Animal models of human head injury. J. Neurotrauma. 11:1994;357-368.
123. Gennarelli T. A., Thibautlt L. E., Adams J. H., Graham D. I., Thompson C. J., Marcincin R. P. Diffuse axonal injury and traumatic coma in the primate. Ann. Neurol. 12:1982;564-574.
124. Gipsen W. H. Phosphoprotein B-50 and phosphoinositides in brain synaptic plasma membranes: a possible feedback relationship. Biochem. Soc. Trans. 14:1986;163-165.
125. Girault J. A., Hemmings H. C. Jr, Williams K. R., Nairn A. C., Greengard P. Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II. J. Biol. Chem. 264:1989;21748-21759.
126. Goldenring J. R., Lasher R. S., Vollano M. L., Ueda T., Saito S., Sternberg N. H., Sternberg L. A., Lorenzo R. L. Association of synapsin I with neuronal cytoskeleton. J. Biol. Chem. 261:1986;8495-8504.
127. Gonzales C., Lin R. C. S., Chesselet M. F. Relative sparing of GABAergic interneurons in the striatum of gerbils with ischemia-induced lesions. Neurosci. Lett. 135:1992;53-58.
128. Goslin K., Schreyer D. J., Skene J. H. P., Banker G. Development of neuronal polarity: GAP-43 distinguishes axonal from dendritic growth cones. Nature. 336:1988;672-674.
129. Goto S., Yamamoto H., Fukunaga K., Iwasa T., Matsukado Y., Miyamoto E. Dephosphorylation of microtubule-associated protein 2, τ factor, and tubulin by calcineurin. J. Neurochem. 45:1985;276-283.
130. Goto S., Matsukado Y., Mihara Y., Inoue N., Miyamoto E. The distribution of calcineurin in rat brain by light and electron microscopic immunohistochemistry and enzyme-immunoassay. Brain Res. 397:1986;161-172.
131. Goto S., Matsukado Y., Miyamoto E., Yamada M. Morphological characterization of the rat striatal neurons expressing calcineurin immunoreactivity. Neuroscience. 22:1987;189-201.
132. Goto S., Nagahiro S., Korematsu K., Ushio Y. Striatonigral involvement following transient focal cerebral ischemia in the rats: an immunohistochemical study on a reversible ischemia model. Acta Neuropath. 85:1993;515-520.
133. Gout I., Dhand R., Hiles I. D., Fry M. J., Panayotou G., Das P., Truong O., Totty N. F., Hsuan J., Booker G. W., Campbell I., Waterfield M. The GTPase dynamin binds to and is activated by a subset of SH3 domains. Cell. 75:1993;25-36.
134. Graff J. M., Gordon J. I., Blackshear P. J. Myristoylated and nonmyristoylated forms of a protein are phosphorylated by protein kinase C. Science. 246:1989;503-506.
135. Graff J. M., Stumpo D. J., Blackshear P. J. Molecular cloning, sequence, and expression of a cDNA encoding the chicken myristoylated alanine-rich C kinase substrate (MARCKS). Mol. Endocrinol. 3:1989;1903-1906.
136. Graff J. M., Young T. N., Johnson J. D., Blackshear P. J. Phosphorylation-regulated calmodulin binding to a prominent cellular substrate for protein kinase C. J. Biol. Chem. 264:1989;21818-21823.
137. Graham D. I., Lawrence A. E., Adams J. H., Doyle D., McLellan D. R. Brain damage in non-missile head injury without high intracranial pressure. J. Clin. Pathol. 41:1988;34-37.
138. Graham D. I., Ford I., Adams J., Doyle D., Teasdale G. M., Lawrence A. E., McLellan D. R. Ischemic brain damage is still common in fatal non-missile head injury. J. Neurol. Neurosurg. Psychiat. 52:1989;346-350.
139. Greenwood J. A., Scott C. W., Spreen R. C., Caputo C. B., Johnson G. V. Casein kinase II preferentially phosphorylates human tau isoforms containing an amino-terminal insert. Identification of threonine 39 as the primary phosphate acceptor. J. Biol. Chem. 269:1994;4373-4380.
140. Griffith J. P., Kim J. L., Kim E. E., Sintchak M. D., Thomson J. A., Fitzgibbon M. J., Fleming M. A., Caron P. R., Hsiao K., Navia M. A. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell. 82:1995;507-522.
141. Guerini D., Klee C. B. Cloning of human calcineurin A: evidence for two isozymes and identification of a polyproline structural domain. Proc. Natl Acad. Sci. USA. 86:1989;9183-9187.
142. 2+ and calmodulin-regulated protein phosphatase. Ad. Prot. Phosphatases. 6:1991;391-410.
143. 2+/calmodulin-stimulated protein phosphatase. DNA. 8:1989;675-682.
144. Guerini D., Montell C., Klee C. B. Molecular cloning and characterization of the genes encoding the two subunits of Drosophila melanogaster calcineurin. J. Biol. Chem. 267:1992;22542-22549.
145. Gustafson E. L., Girault J. A., Hemmings H. C. Jr, Nairn A. C., Greengard P. Immunocytochemical localization of inhibitor-1 in rat brain. J. Comp. Neurol. 310:1991;170-188.
146. Hallenbeck J. M., Dutka A. J., Tanishima T., Kochanek P. M., Kumaroo K. K., Thompson C. B., Obrenovitch T. P., Contreras T. J. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke. 17:1986;246-253.
147. Halpain S., Girault J. A., Greengard P. Activation of NMDA receptors induces dephosphorylation of DARRP-32 in rat striatal slices. Nature. 343:1990;369-372.
148. Hansen A. J. Extracellular potassium concentration in juvenile and adult rat brain cortex during anoxia. Acta Physiol. Scand. 99:1977;412-420.
149. Hansen A. J. Effect of anoxia on ion distribution in the brain. Phyiol. Rev. 165:1985;101-148.
150. Hara H., Onodera H., Yoshidomi M., Matsuda Y., Kogure K. Staurosporine, a novel protein kinase C inhibitor, prevents postischemic neuronal damage in the gerbil and rat. J. Cereb. Blood Flow Metab. 10:1990;646-653.
151. Hartwig J. H., Thelen M., Rosen A., Janmey P. A., Nairn A. C., Aderem A. MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. Nature. 356:1992;618-622.
152. 2+/calmodulin-dependent protein kinase II and protein kinase C. J. Biol. Chem. 264:(16):1989;524-529.
153. Hashimoto Y., Perrino B. A., Soderling T. R. Identification of an autoinhibitory domain in calcineurin. J. Biol. Chem. 265:1990;1924-1927.
154. Hayes R. L. Central nervous system trauma: Neurotransmitter mediated mechanisms of traumatic brain injury: acetylcholine and excitatory amino acids. J. Neurotrauma. 9:(suppl. 1):1991;s157-164.
155. Heinel L. A., Rubin S., Rosenwasser R. H., Vasthare U. S., Tuma R. F. Leukocyte involvement in cerebral infarct generation after ischemia and reperfusion. Brain Res. Bull. 34:1994;137-141.
156. Hemmings H. C. Jr, Greengard P., Tung H. Y. L., Cohen P. DARRP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature. 310:1984;503-505.
157. Hemmings H. C. Jr, Nairn A. C., Aswad D. W., Greengard P. DARPP-32, a dopamine-andadenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brainregions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus. J. Neurosci. 4:1984;99-110.
158. Hemmings H. C. Jr, Girault J. A., Nairn A. C., Bertuzzi G., Greengard P. Distribution of protein phosphatase inhibitor-1 in brain and peripheral tissue of various species: comparison with DARRP-32. J. Neurochem. 59:1992;1053-1061.
159. Herskovits J. S., Shpetner H. S., Burgess C. C., Vallee R. B. Microtubules and Src homology 3 domains stimulate the dynamin GTPase via its C-terminal domain. Proc. Natl Acad. Sci. USA. 90:1993;11468-11472.
160. Ho A. M., Jain J., Rao A., Hogan P. G. Expression of the transcription factor NFATp in a neuronal cell line and in the murine nervous system. J. Biol. Chem. 269:1994;28181-28186.
161. Hoey T., Sun Y. A., Williamson K., Xu X. Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. Immunity. 2:1995;461-472.
162. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science. 252:1991;851-853.
163. 2+-dependent processes. Proc. Natl Acad. Sci. USA. 83:1986;3733-3737.
164. Hosoya, H., Komatsu, S., Shimizu, T., Inagaki, M., Ikegami, M., Yazaki, K. (1994) Phosphorylation of dynamin by cdc2 kinase. 202, 1127-1133.
165. Hoyos B., Ballard D. W., Bohnlein E., Siekevitz M., Greene W. C. Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression. Science. 244:1989;457-460.
166. Hu B. R., Wieloch T. Stress-induced inhibition of protein synthesis initiation, modulation of initiation factor 2 and guanine nucleotide exchange factor activities following transient cerebral ischemia in the rat. J. Neurosci. 13:1993;1830-1838.
167. Hu B. R., Wieloch T. Tyrosine phosphorylation and activation of mitogen-activated protein kinase in the rat brain following transient cerebral ischemia. J. Neurochem. 62:1994;1357-1367.
168. Huang F. L., Glinsmann W. H. Separation and characterization of two phosphorylase phosphatase inhibitors from rabbit skeletal muscle. Eur. J. Biochem. 70:1976;419-426.
169. Huang Z., Huang P. L., Panahian N., Dalkara T., Fishman M. C., Moskowitz M. A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1994;1883-1885.
170. Hunter T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell. 80:1995;225-236.
171. Huttner W. B., Greengard P. Multiple phosphorylation sites in protein I and their differential regulation by cyclic AMP and calcium. Proc. Natl Acad. Sci. USA. 76:1979;5402-5406.
172. Huttner W. B., Schiebler W., Greengard P., De Camilli P. Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J. Cell. Biol. 96:1983;1374-1388.
173. Ide T., Morikawa E., Kirino T. An immunosuppressant, FK506, protects hippocampal neurons from forebrain ischemia in the mongolian gerbil. Neurosci. Lett. 204:1996;157-160.
174. Ikegami S., Kato A., Kudo Y., Kuno T., Ozawa F., Inokuchi K. A facilitatory effect on the induction of long-term potentiation in vivo by chronic administration of antisense oligodeoxynucleotides against catalytic subunits of calcineurin. Mol. Brain Res. 41:1996;183-191.
175. Imaizumi S., Woolworth V., Fishman B. A. Liposome-entrapped superoxide dismutase reduced cerebral infarction in cerebral ischemia in rats. Stroke. 21:1990;1312-1317.
176. Ingebritsen T. S., Cohen P. Protein phosphatases: properties and role in cellular regulation. Science. 221:1983;331-338.
177. Inuzuka T., Tamura A., Sato S., Kirino T., Yanagisawa K., Toyoshima I., Miyatake T. Changes in the concentrations of cerebral proteins following occlusion of the middle cerebral artery in rats. Stroke. 21:1990;917-922.
178. Ito A., Hashimoto T., Hirai M., Takeda T., Shuntoh H., Kuno T., Tanaka C. The complete primary structure of calcineurin A, a calmodulin binding protein homologous with protein phosphatases 1 and 2A. Biochem. biophys. Res. Commun. 163:1989;1492-1497.
179. Jain J., McCaffrey P. G., Miner Z., Kerppola T. K., Lambert J. N., Verdine G. L., Curran T., Rao A. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature. 365:1993;352-355.
180. Jameson L., Frey T., Zeeberg B., Daldorf F., Caplow M. Inhibition of microtubule assembly by phosphorylation of microtubule-associated proteins. Biochemistry. 19:1980;2472-2479.
181. Jayaraman T., Brillantes A., Timerman A. P., Fleischer S., Erdjument-Bromage H., Tempst P., Marks A. R. FK506-binding protein associated with the calcium release channel (ryanodine receptor). J. Biol. Chem. 267:1992;9474-9477.
182. Jenkins L. W., Moszynski K., Lyeth B. G., Lewelt W., DeWitt D. S., Allen A., Dixon C. E., Povlishock J. T., Majewski T. J., Clifton G. L. Increased vulnerability of the mildly traumatized rat brain to cerebral ischemia: the use of controlled secondary ischemia as a research tool to identify common or different mechanisms contributing to mechanical and ischemic brain injury. Brain Res. 477:1989;211-224.
183. Johnson E. M., Ueda T., Maeno H., Greengard P. Adenosine 3′,5-monophosphate-dependent phosphorylation of a specific protein in synaptic membrane fractions from rat cerebrum. J. Biol. Chem. 247:1972;5650-5662.
184. 2+/calmodulin-dependent protein kinase II: metabolic and functional consequences. J. Neurochem. 59:1992;2056-2062.
185. Kanai Y., Hediger M. A. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature. 360:1992;467-471.
186. Katayama Y., Becker D. P., Tamura T., Hovda D. Massive increase in extracellular potassium and indiscriminative glutamate release after concussive brain injury. J. Neurosurg. 73:1990;889-900.
187. Katayama Y., Tamura T., Becker D. P., Tsubokawa T. Calcium-dependent component of massive increase in extracellular potassium during ischemia as demonstrated by microdialysis in vivo. Brain Res. 567:1991;57-63.
188. Katayama Y., Maeda T., Koshinaga M., Kawamata T., Tsubokawa T. Role of excitatory amino acid-mediated ionic fluxes in traumatic brain injury. Brain Pathol. 5:1995;427-435.
189. Katz F., Ellis L., Pfenninger H. Nerve growth cones isolated from fetal brain. III. Calcium-dependent protein phosphorylation. J. Neurosci. 5:1985;1402-1411.
190. Kawamata T., Katayama Y., Hovda D. A., Yoshino A., Becker D. P. Administration of excitatory amino acid antagonists via microdialysis attenuates the increase in glucose utilization seen following concussive brain injury. J. Cereb. Blood Flow Metab. 12:1992;12-24.
191. Kawamata T., Katayama Y., Hovda D. A., Yoshino A., Becker D. P. Lactate accumulation following concussive brain injury. The role of ionic fluxes induced by excitatory amino acids. Brain Res. 674:1995;196-204.
192. Kayyali U. S., Zhang W., Yee A. G., Seidman J. G., Potter H. Cytoskeletal change in the brains of mice lacking calcineurin Aα J. Neurochem. 68:1997;1668-1678.
193. Kennedy M. B., Greengard P. Two calcium/calmodulin-dependent protein kinases, which are highly concentrated in brain, phosphorylate protein I at distinct sites. Proc. Natl Acad. Sci. USA. 78:1981;1293-1297.
194. Kerr J. F. R., Wyllie A. H., Currie A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
195. Kincaid R. L. Calmodulin-dependent protein phosphatases from microorganisms to man. A study in structural conservatism and biological diversity. Adv. Second Messenger Phosphoprotein Res. 27:1993;1-23.
196. Kincaid R. L., Balaban C. D., Billingsley M. L. Differential localization of calmodulin-dependent enzymes in rat brain: evidence for selective expression of cyclic nucleotide phosphodiesterase in specific neurons. Proc. Natl Acad. Sci. USA. 84:1987;1118-1122.
197. Kincaid R. L., Takayama H., Billingsley M. L., Sitkovsky M. V. Differential expression of calmodulin-binding proteins in B, T lymphocytes and thymocytes. Nature. 330:1987;176-178.
198. Kincaid R. L., Giri P. R., Higuchi S., Tamura J., Dixon S. C., Marietta C. A., Amorese D. A., Martin B. M. Cloning and characterization of molecular isoforms of the catalytic subunit of calcineurin using nonisotopic methods. J. Biol. Chem. 265:1990;11312-11319.
199. King M. M., Huang C. Y. Activation of calcineurin by nickel ions. Biochem. biophys. Res. Commun. 114:1983;955-961.
200. King M. M., Huang C. Y. The calmodulin-dependent activation and deactivation of the phosphoprotein phosphatase, calcineurin, and the effect of nucleotides, pyrophosphate, and divalent metal ions. Identification of calcineurin as a Zn and Fe metalloenzyme. J. Biol. Chem. 259:1984;8847-8856.
201. King M. M., Huang C. Y., Chock P. B., Nairn A. C., Hemmings H. C. Jr, Chan K. F. J., Greengard P. Mammalian brain phosphoproteins as substrates for calcineurin. J. Biol. Chem. 259:1984;8080-8083.
202. Kinouchi H., Epstein C. J., Mizui T., Carlson E. J., Chen S. F., Chan P. H. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc. Natl Acad. Sci. USA. 88:1991;11158-11162.
203. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239:1982;57-69.
204. Kirino T., Tamura A., Sano K. Chronic maintenance of presynaptic terminals in gliotic hippocampus following ischemia. Brain Res. 510:1990;17-25.
205. Kirino T., Tsujita Y., Tamura A. Induced tolerance to ischemia in gerbil hippocampal neurons. J. Cereb. Blood Flow Metab. 11:1991;299-307.
206. Kissinger C. R., Parge H. E., Knighton D. R., Lewis C. T., Pelletier L. A., Tempczyk A., Kalish V. J., Tucker K. D., Showalter R. E., Moomaw E. W. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature. 378:1995;641-644.
207. Kitagawa K., Matsumoto M., Niinobe M., Mikoshiba K., Hata R., Ueda N., Handa N., Fukunaga R., Isaka Y., Kimura K., Kamada T. Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage. Immunohistochemical investigation of dendritec damage. Neuroscience. 31:1989;401-411.
208. Kitagawa K., Matsumoto M., Oda T., Niinobe M., Hata R., Handa N., Fukunaga R., Isaka Y., Kimura K., Maeda H., Mikoshiba K., Kamada T. Free radical generation during brief period of cerebral ischemia may trigger delayed neuronal death. Neuroscience. 35:1990;551-558.
209. Kitagawa K., Matsumoto M., Tagaya M., Hata R., Ueda H., Niinobe M., Handa N., Fukunaga R., Kimura K., Mikoshiba K. 'Ischemic tolerance' phenomenon found in the brain. Brain Res. 528:1990;21-24.
210. Kitagawa K., Matsumoto M., Sobue K., Tagaya M., Okabe T., Niinobe M., Ohtsuki T., Handa N., Kimura K., Mikoshiba K., Kamada T. The synapsin I brain distribution in ischemia. Neuroscience. 46:1992;287-299.
211. Klauck T. M., Faux M. C., Labudda K., Langeberg L. K., Laken S., Scott J. D. Coordination of three signaling enzymes by AKAP79, a mammalian scaffold protein. Science. 271:1996;1589-1592.
212. Klee C. B. Concerted regulation of protein phosphorylation and dephosphorylation by calmodulin. Neurochem. Res. 16:1991;1059-1065.
213. Klee C. B., Haiech J. Concerted role of calmodulin and calcineurin in calcium regulation. Ann. N.Y. Acad. Sci. 356:1980;43-54.
214. Klee C. B., Krinks M. H. Purification of cyclic 3′,5′-nucleotide phosphodiesterase inhibitory protein by affinity chromatography on activator protein coupled to Sepharose. Biochemistry. 17:1978;120-126.
215. Klee C. B., Vanaman T. C. Calmodulin. Adv. Prot. Chem. 35:1982;213-321.
216. Klee C. B., Crouch T. H., Krinks M. H. Calcineurin: a calcium- and calmodulin-binding protein of nervous system. Proc. Natl Acad. Sci. USA. 76:1979;6270-6273.
217. Klee C. B., Krinks M. H., Manalan A. S., Cohen P., Stewart A. A. Isolation and characterization of bovine brain calcineurin: a calmodulin-stimulated protein phosphatase. Meth. Enzymol. 102:1983;227-244.
218. Klee C. B., Draetta G. F., Hubbard M. J. Calcineurin. Adv. Enzymol. 61:1988;149-200.
219. Knowles R. G., Palacios M., Palmer R. M. J., Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl Acad. Sci. USA. 86:1989;5159-5162.
220. Kobayashi M., Lust W. D., Passonneau J. V. Concentration of energy metabolites and cyclic nucleotides during and after ischemia in the gerbil cerebral cortex. J. Neurochem. 29:1977;53-59.
221. Kontos H. A., Wei E. P. Superoxide production in experimental brain injury. J. Neurosurg. 64:1986;803-807.
222. Krueger B. K., Form J., Greengard P. Depolarization-induced phosphorylation of specific proteins, mediated by calcium ion influx, in rat brain synaptosomes. J. Biol. Chem. 252:1977;2764-2773.
223. Kuno T., Takeda T., Hirai M., Ito A., Mukai H., Tanaka C. Evidence for a second isoform of the catalytic subunit of calmodulin-dependent protein phosphatase (calcineurin A). Biochem. biophys. Res. Commun. 165:1989;1352-1358.
224. Kuwaki T., Satoh H., Ono T., Shibayama F., Yamashita T., Nishimura T. Nivadipine attenuates ischemic degradation of gerbil brain cytoskeletal proteins. Stroke. 20:1989;78-83.
225. Lafon-Cazal M., Pietri S., Culcasi S., Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature. 364:1993;535-537.
226. Lee K. S., Frank S., Vanderklish P., Arai A., Lynch G. Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc. Natl Acad. Sci. USA. 88:1991;7233-7237.
227. Lehmann A. Pharmacological protection against the toxicity of N-methyl-D-aspartate in immature rat cerebellar slices. Neuropharmacology. 26:1987;1751-1761.
228. 2+. J. Biol. Chem. 259:1984;8801-8807.
229. 2+ and transition metal ions. Eur. J. Biochem. 144:1984;447-452.
230. Li Y., Chopp M., Jiang N., Zhang Z. G., Zaloga C. Induction of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats. Stroke. 26:1995;1252-1258.
231. Li Y., Sharov V. G., Jiang N., Zaloga C., Sabbah H. N., Chopp M. Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat. Am. J. Pathol. 146:1995;1045-1051.
232. 2+-dependent phosphatase. Nature. 369:1994;235-239.
233. Linnik M. D., Miller J. A., Spinkle-Cavallo J., Mason P. J., Thompson F. Y., Montgomery L. R., Schroeder K. K. Apoptotic DNA fragmentation in the rat cerebral cortex induced by permanent middle cerebral artery occlusion. Mol. Brain Res. 32:1995;116-124.
234. Lipton S. A. Calcium channel antagonists in the prevention of neurotoxicity. Adv. Pharmacol. 22:1991;271-297.
235. Lipton S. A. Molecular mechanisms of trauma-induced neuronal degeneration. Curr. Opin. Neurol. Neurosurg. 6:1993;588-596.
236. Lipton S. A., Rosenberg P. A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330:1994;613-622.
237. Lipton S. A., Choi Y. B., Pan Z. H., Lei S. Z., Chen H. S., Sucher N. J., Loscalzo J., Singel D. J., Stamler J. S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
238. Lisman J. A mechanism of Hebb and anti-Hebb processes underlying learning and memory. Proc. Natl Acad. Sci. USA. 86:1989;9574-9578.
239. Litersky J. M., Johnson G. V. Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. J. Biol. Chem. 267:1992;1563-1568.
240. Liu J., Farmer J. D., Lane W. S., Friedman J., Weissman I., Schreiber S. L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 66:1991;807-815.
241. Liu J. P., Powell K. A., Sudhof T. C., Robinson P. J. Dynamin I is a Ca(2+)-sensitive phospholipid-binding protein with very high affinity for protein kinase C. J. Biol. Chem. 269:1994;21043-21050.
242. Liu J. P., Sim A. T. R., Robinson P. J. Calcineurin inhibition of dynamin I GTPase activity coupled to nerve terminal depolarization. Science. 265:1994;970-973.
243. Liu Y., Albers M. W., Wandless T. J., Luan S., Alberg D. G., Belshaw P. J., Cohen P., Mackintosh C., Klee C. B., Schreiber S. L. Inhibition of T-cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry. 31:1992;3896-3901.
244. Liu Y. C., Storm D. R. Dephosphorylation of neuromodulin by calcineurin. J. Biol. Chem. 264:1989;12800-12804.
245. Liu X. H., Kato H., Nakata N., Kogure K., Kato K. An immunohistochemical study of copper/zinc superoxide dismutase and manganese superoxide dismutase in rat hippocampus after transient cerebral ischemia. Brain Res. 625:1993;29-37.
246. Liu Y. J., Mason D. Y., Johnson G. D., Abbot S., Gregory C. D., Hardie D. L., Gordon J., MacLennan I. C. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur. J. Immun. 21:1991;1905-1910.
247. Llinas R., McGuinness T. L., Leonard C. S., Sugimori M., Greengard P. Intraterminal injection of synapsin I or calcium/calmodulin-dependent protein kinase II alters neurotransmitter release at the squid giant synapse. Proc. Natl Acad. Sci. USA. 82:1985;3035-3039.
248. Lyons W. E., George E. B., Dawson T. M., Steiner J. P., Snyder S. H. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc. Natl Acad. Sci. USA. 91:1994;3191-3195.
249. MacDougall L. K., Campbell D. D., Hubbard M. J., Cohen P. Partial structure and hormonal regulation of rabbit liver inhibitor-1; distribution of inhibitor-1 and inhibitor-2 in rabbit and rat tissues. Biochem. biophys. Acta. 1010:1988;212-226.
250. 2+ release channel. J. Biol. Chem. 268:1993;13765-13768.
251. Malenka R. C. Synaptic plasticity in the hippocampus: LTP and LTD. Cell. 78:1994;535-538.
252. Manev H., Favaron M., Siman R., Guidotti A. Glutamate neurotoxicity is independent of calpain I inhibition in primary cultures of cerebellar granule cells. J. Neurochem. 57:1991;1288-1295.
253. Marion D. W., Penrod L. E., Kelsey S. F., Obrist W. D., Kochanek P. M., Palmer A. M., Wisniewski S. R., DeKosky S. T. Treatment of traumatic brain injury with moderate hypothermia. N. Engl. J. Med. 336:1997;540-546.
254. Marletta M. A. Nitric oxide synthase: aspects concerning structure and catalysis. Cell. 78:1994;927-930.
255. Martzen M. R., Slemmon J. R. The dendritic peptide neurogranin can regulate a calmodulin-dependent target. J. Neurochem. 64:1995;92-100.
256. Matsui H., Doi A., Itano T., Shimada M., Wang J. H., Hatase O. Immunohistochemical localization of calcineurin, calmodulin-stimulated phosphatase, in the rat hippocampus using a monoclonal antibody. Brain Res. 402:1987;193-196.
257. Matsumoto K., Yamada K., Hayakawa T., Sakaguchi T., Mogami H. RNA synthesis and processing in the gerbil brain following transient hindbrain ischemia. Neurol. Res. 12:1990;45-48.
258. Matsuyama T., Michishita H., Nakamura H., Tsuchiyama M., Shimizu S., Watanabe K., Sugita M. Induction of copper/zinc superoxide dismutase in gerbil hippocampus after ischemia. J. Cereb. Blood Flow Metab. 13:1993;135-144.
259. Mayford M., Abel T., Kandel E. R. Transgenic approach to cognition. Curr. Opin. Neurobiol. 5:1995;141-148.
260. Meiri K. F., Pfenningger K. H., Willard M. B. Growth-associated protein, GAP-43, a polypeptide that is induced when neurons extend axons, is a component of growth cones and corresponds to pp46, a major polypeptide of a subcellular fraction enriched in growth cones. Proc. Natl Acad. Sci. USA. 83:1986;3537-3541.
261. Miller B., Sarantis M., Traynelis S. F., Attwell D. Potentiation of NMDA receptor currents by arachidonic acid. Nature. 355:1992;722-725.
262. Mittal C. K., Jadhav A. L. Calcium-dependent inhibition of constitutive nitric oxide synthase. Biochem. biophys. Res. Commun. 203:1994;8-15.
263. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
264. Montoro R. J., Diaz-Nido J., Avila J., Lopez-Barneo J. N-Methyl-D-aspartate stimulates the dephosphorylation of microtubule-associated protein 2 and potentiates excitatory synaptic pathways in the rat hippocampus. Neuroscience. 54:1993;859-871.
265. Mori E., del Zoppo G.J., Chambers J. D., Copeland B. R., Arfors K. E. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke. 23:1992;712-718.
266. 2+/calmodulin-dependent protein kinase II and calcineurin in the hippocampus of rat brain after transient forebrain ischemia. J. Neurochem. 58:1992;1798-1809.
267. 2+/calmodulin-dependent protein kinase II activity in cultured rat hippocampal neurons. J. Neurochem. 64:1995;2132-2139.
268. Morioka M., Nagahiro S., Fukunaga K., Miyamoto E., Ushio Y. Calcineurin in the adult rat hippocammpus: different distribution in CA1 and CA3 subfields. Neuroscience. 78:1997;673-684.
269. Mulkey R. M., Endo S., Shenolokar S., Malenka R. Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. Nature. 369:1994;486-488.
270. Nairn A. C., Hemings H. C. Jr, Walaas S. I., Greengard P. DARRP-32 and phosphatase inhibitor-1, two structurally related inhibitors of protein phosphatase-1, are both present in striatonigral neurons. J. Neurochem. 50:1988;257-262.
271. Nakagomi T., Kirino T., Kanemitsu H., Tsujita Y., Tamura A. Early recovery of protein synthesis following ischemia in hippocampal neurons with induced tolerance in the gerbil. Acta Neuropathol. 86:1993;10-15.
272. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science. 258:1992;597-603.
273. Nakata N., Kato H., Liu Y., Kogure K. Effects of pretreatment with sublethal ischemia on the extracellular glutamate concentrations during secondary ischemia in the gerbil hippocampus evaluated with intracerebral microdialysis. Neurosci. Lett. 138:1992;86-88.
274. Nauta W. J. H., Domesick V. B. Afferent and efferent relationships of the basal ganglia. Ciba Found Symp. 107:1984;3-23.
275. Nichols R. A., Suplick G. R., Brown J. M. Calcineurin-mediated protein dephosphorylation in brain nerve terminals regulates the release of glutamate. J. Biol. Chem. 269:1994;23817-23823.
276. Nilsson B., Nordstrom C. H. Experimental head injury in the rat. Part 3: cerebral blood flow and oxygen consumption after concussive impact acceleration. J. Neurosurg. 47:1977;262-273.
277. Nilsson B., Nordstrom C. H. Rate of cerebral energy consumption in concussive head injury in the rat. J. Neurosurg. 47:1977;274-281.
278. Nilsson B., Ponten U. Experimental head injury in the rat. Part 2: regional brain energy metabolism in concussive trauma. J. Neurosurg. 47:1977;252-261.
279. 2+ levels following cortical compression contusion trauma in rats. J. Cereb. Blood Flow Metab. 13:1993;183-192.
280. Nimmo G. A., Cohen P. The regulation of glycogen metabolism. Purification and characterization of protein phosphatase inhibitor-1 from rabbit skeletal muscle. Eur. J. Biochem. 87:1978;341-351.
281. Nishinaka Y., Sugiyama S., Yokota M., Saito H., Ozawa T. Protective effect of FK506 on ischemia/reperfusion-induced myocardial damage in canine heart. J. Cardiovasc. Pharmacol. 21:1993;448-454.
282. Norman S. G., Johnson G. V. Compromised mitochondrial function results in dephosphorylation of tau through a calcium-dependent process in rat brain cerebral cortical slices. Neurochem. Res. 19:1994;1151-1158.
283. Nowak T. S. Jr, Fried R. L., Lust W. D., Passonneau J. V. Changes in brain energy metabolism and protein synthesis following transient bilateral ischemia in the gerbil. J. Neurochem. 44:1985;487-494.
284. Ogawa N., Tanaka K., Kondo Y., Asanuma M., Mizukawa K., Mori A. The preventive effect of cyclosporin A, an immunosuppressant, on the late onset reduction of muscarinic acetylcholine receptors in gerbil hippocampus after forebrain ischemia. Neurosci. Lett. 152:1993;173-176.
285. O'Keefe S. J., Tamura J., Kincaid R. L., Tocci M. J., O'Neill E. A. FK-506-and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature. 357:1992;692-694.
286. Olney J. W. Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate. Science. 164:1969;719-721.
287. Onodera H., Iijima K., Kogure K. Mononucleotide metabolism in the rat brain after transient ischemia. J. Neurochem. 46:1986;1704-1710.
288. Ouimet C. C., Miller P. E., Hemmings H. C. Jr, Walaas S. I., Greengard P. DARRP-32, a dopamine and adenosine 3′:5′-monophosphate regulated phosphoprotein enriched in dopamine-innervated brain regions. III. immunocytochemical localization. J. Neurosci. 4:1984;111-124.
289. Ouimet C. C., Wang J. K., Walaas S. I., Albert K. A., Greengard P. Localization of the MARCKS (87 kDa) protein, a major specific substrate for protein kinase C, in rat brain. J. Neurosci. 10:1990;1683-1698.
290. Pallen C. J., Wang J. H. Calmodulin-stimulated dephosphorylation of p-nitrophenyl phosphate and free phosphotyrosine by calcineurin. J. Biol. Chem. 258:1983;8550-8553.
291. Pallen C. J., Valentine K. A., Wang J. H., Hollenberg M. D. Calcineurin-mediated dephosphorylation of the human placental membrane receptor for epidermal growth factor urogastrone. Biochemistry. 24:1985;4727-4730.
292. Petit C. K., Feldman E., Pulsinelli W. A., Plum F. Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology. 37:1987;1281-1286.
293. Petrucci T. C., Morrow J. S. Synapsin I: an actin-bundling protein under phosphorylation control. J. Cell Biol. 105:1987;1355-1363.
294. Picone C. M., Grotta J. C., Earls R., Strong R., Dedman J. Immunohistochemical determination of calcium-calmodulin binding predicts neuronal damage after global ischemia. J. Cereb. Blood Flow Metab. 9:1989;805-811.
295. Pines G., Danbolt N. C., Bjøras M., Zhang Y., Bendahan A., Eide L., Koepsell H., Storm-Mathisen J., Seeberg E., Kanner B. I. Cloning and expression of a rat brain L-glutamate transporter. Nature. 360:1992;464-467.
296. Posmantur R. M., Kampfl A., Taft W. C., Bhattacharjee M., Dixon C. E., Bao J., Hayes R. L. Diminished microtubule-associated protein 2 (MAP2) immunoreactivity following cortical impact brain injury. J. Neurotrauma. 13:1996;125-137.
297. Povlishock J. T., Hayes R. L., Michel M. E., Mcintosh G. W. Workshop on animal models of traumatic brain injury. J. Neurotrauma. 11:1994;723-732.
298. Pulsinelli W. A., Duffy T. E. Reginal energy balance in rat brain after transient forebrain ischemia. J. Neurochem. 40:1983;1500-1503.
299. Pulsinelli W. A., Brierley J. B., Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11:1982;491-498.
300. Quinlan E. M., Halpain S. Postsynaptic mechanismms for bidirectional control of MAP2 phosphorylation by glutamate receptors. Neuron. 16:1996;357-368.
301. Raffaelli N., Yamauchi P. S., Purich D. L. Microtubule-associated protein autophosphorylation alters in vitro microtubule dynamic instability. FEBS Lett. 296:1992;21-24.
302. Raman I. M., Tong G., Jahr C. E. β-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase. Neuron. 16:1996;415-421.
303. Rehncrona S., Westerberg E., Akesson B., Siesjö B. K. Brain cortical fatty acids and phospholipids during and following complete and severe incomplete ischemia. J. Neurochem. 38:1982;84-93.
304. Represa A., Deloulme J. C., Sensenbrenner M., Ben-Ari Y., Baudier J. Neurogranin: immunocytochemical localization of a brain-specific protein kinase C substrate. J. Neurosci. 10:1990;3782-3792.
305. Roberts E., Kuriyama K. Biochemical-physiological correlations in studies of the gamma-aminobutyric acid system. Brain Res. 8:1968;1-35.
306. Robinson P. J. Differential stimulation of protein kinase C activity by phorbol ester or calcium/phosphatidylserine in vitro and in intact synaptosomes. J. Biol. Chem. 267:1992;21637-21644.
307. Robinson P. J., Dunkley P. R. Depolarisation-dependent protein phosphorylation in rat cortical synaptosomes: factors determining the magnitude of the response. J. Neurochem. 41:1983;909-918.
308. Robinson P. J., Sontag J. M., Liu J. P., Fykse E. M., Slaughter C., McMahon H., Südhof T. C. Dynamin GTPase regulated by protein kinase C phosphorylation in nerve terminals. Nature. 365:1993;163-166.
309. Robinson P. J., Liu J. P., Powell K. A., Fyske E. M., Südhof T. C. Phosphorylation of dynamin I and synaptic-vesicle recycling Trends. Neurosci. 17:1994;348-353.
310. Ruff V. A., Leach K. L. Direct demonstration of NFATp dephosphorylation and nuclear localization in activated HT-2 cells using a specific NFATp polyclonal antibody. J. Biol. Chem. 270:1995;22602-22607.
311. Ryan T. A., Reuter H., Wendland B., Schweizer F. E., Tsien R. W., Smith S. J. The kinetics of synaptic vesicle recycling measured at single presynaptic boutons. Neuron. 11:1993;713-724.
312. Schiebler W., Jahn R., Rothlein J. P., Greengard P. Characterization of synapsin I binding to small synaptic vesicles. J. Biol. Chem. 261:1986;8383-8390.
313. Schmidley J. W. Free radicals in central nervous system ischemia. Stroke. 21:1990;1086-1090.
314. Schreiber S. L., Crabtree G. R. The mechanism of action of cyclosporin A and FK506. Immunol. Today. 13:1992;136-142.
315. Seki K., Chen H. C., Huang K. P. Dephosphorylation of protein kinase C substrates, Neurogranin, Neuromodulin, and MARCKS, by calcineurin and protein phosphatases 1 and 2A. Arch. Biochem. Biophys. 316:1995;673-679.
316. Seubert P., Lee K., Lynch G. Ischemia triggers NMDA receptor-linked cytoskeletal proteolysis in hippocampus. Brain Res. 492:1989;366-370.
317. Sharkey J., Butcher S. P. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischemia. Nature. 371:1994;336-339.
318. Sharkey J., Crawford J. H., Butcher S. P., Marston H. M. Tacrolimus (FK506) ameliorates skilled motor deficits produced by middle cerebral artery occlusion in rats. Stroke. 27:1996;2282-2286.
319. Shaw K.T-Y., Ho A. M., Raghavan A., Kim J., Jain J., Park J., Sharma S., Rao A., Hogan P. G. Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc. Natl Acad. Sci. USA. 92:1995;11205-11209.
320. 2+-activated cell death in mammalian cells. J. Cell. Biol. 131:1995;735-743.
321. Shibasaki F., Price E. R., Milan D., McKeon F. Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature. 382:1996;370-373.
322. Shibasaki F., Kondo E., Akagi T., McKeon F. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature. 386:1997;728-731.
323. Shigeno T., Mima T., Takakura K., Graham D. I., Kato G., Hashimoto Y., Furukawa S. Amelioration of delayed neuronal death in the hippocampus by nerve growth factor. J. Neurosci. 11:1991;2914-2919.
324. Shpetner H. S., Vallee R. B. Identification of dynamin, a novel mechanochemical enzyme that mediates interactions between microtubules. Cell. 59:1989;421-432.
325. Shpetner H. S., Vallee R. B. Dynamin is a GTPase stimulated to high levels of activity by microtubules. Nature. 355:1992;733-735.
326. Siesjö B. K., Bentsson F. Calcium fluxes, calcium antagonists, and calcium-related pahology in brain ischemia, hypoglycemia, and apreading depression: a unifying hypothesis. J. Cereb. Blood Flow Metab. 9:1989;127-140.
327. Siesjö B. K., Zhao Q., Pahlmark K., Siesjö P., Katsura K., Folbergrová J. Glutamate, calcium, and free radicals as mediators of ischemic brain damage. Ann. Thrac. Surg. 59:1995;1316-1320.
328. Skene J. H. P., Jacobson R. D., Snipes G. J., McGuire C. B., Norden J. J., Freeman J. A. A protein induced during nerve growth, "GAP43", is a major component of growth-cone membranes. Science. 233:1986;783-786.
329. Slemmon J. R., Martzen M. R. Neuromodulin (GAP-43) can regulate a calmodulin-dependent target in vitro. Biochemistry. 33:1994;5653-5660.
330. Snyder G. L., Fisone G., Greengard P. Phosphorylation of DARPP-32 is regulated by GABA in rat striatum and substantia nigra. J. Neurochem. 63:1994;1766-1771.
331. Snyder S., Sabatini D. Immunophilins and the nervous system. Nature Med. 1:1995;32-37.
332. Steiner J. P., Dawson T. M., Fotuhi M., Glatt C. E., Snowman A. M., Cohen N., Snyder S. H. High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature. 358:1992;584-587.
333. Steiner J. P., Dawson T. M., Fotuhi M., Snyder S. H. Immunophilin regulation of neurotransmitter release. Mol. Med. 2:1996;325-333.
334. 2+-dependent inactivation of calcineurin in brain. FEBS Lett. 374:1995;237-240.
335. 2+- and calmodulin-dependent protein phosphatase: probable identity with calcineurin (CaM-BP80). FEBS Lett. 137:1982;80-84.
336. 2+/calmodulin-dependent protein phosphatase (2B) from rabbit skeletal muscle. Eur. J. Biochem. 132:1983;289-295.
337. 2+-dependent glutamate/aspartate transporter from rat brain. Proc. Natl Acad. Sci. USA. 89:1992;10955-10959.
338. Stumpo D. J., Graff J. M., Albert K. A., Greengard P., Blackshear P. J. Molecular cloning, characterization, and expression of a cDNA encoding the "80- to 87-kDa" myristoylated alanine-rich C kinase substrate: a major cellular substrate for protein kinase C. Proc. Natl Acad. Sci. USA. 86:1989;4012-4016.
339. Su Q., Zhao M., Weber E., Eugster H. P., Ryffel B. Distribution and acitivity of calcineurin in rat tissues. Evidence for post-transcriptional regulation of testis-specific calcineurin B. Eur. J. Biochem. 230:1995;469-474.
340. Szabo S. J., Gold J. S., Murphy T. L., Murphy K. M. Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells: roles for NF-Y and NF-ATc. Mol. Cell. Biol. 13:1993;4793-4805.
341. Taft W. C., Yang K., Dixon C. E., Clifton G. L., Hayes R. L. Hypothermia attenuates the loss of hippocampal microtubule-associated protein 2 (MAP2) following traumatic brain injury. J. Cereb. Blood Flow Metab. 13:1993;796-802.
342. Takahashi H., Manaka S., Sano K. Changes in extracellular potassium concentration in cortex and brain stem during the acute phase of experimental closed head injury. J. Neurosurg. 55:1981;708-717.
343. Takeshima H., Nishimura S., Matsumoto T., Ishida H., Kangawa K., Minamino N., Matsuo H., Ueda M., Hanaoka M., Hirose T., Numa S. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature. 339:1989;439-445.
344. Tallant E. A., Cheung W. Y. Calmodulin-dependent protein phosphatase: a developmental study. Biochemistry. 22:1983;3630-3635.
345. Tallant E. A., Cheung W. Y. Characterization of bovine brain calmodulin-dependent protein phosphatase. Arch. Biochem. Biophys. 232:1984;269-279.
346. Tallant E. A., Cheung W. Y. Activation of bovine brain calmodulin-dependent protein phosphatase by limited trypsinization. Biochemistry. 23:1984;973-979.
347. 2+-dependent protease. Biochemistry. 27:1988;2205-2211.
348. Thilmann R., Xie Y., Kleihues P., Kiessling M. Persistent inhibition of protein synthesis precedes delayed neuronal death in postischemic gerbil hippocampus. Acta Neurropathol. 60:1986;88-93.
349. Timerman A. P., Ogunbumni E., Freund E., Wiederrecht G., Marks A. R., Fleischer S. The calcium release channel of sarcoplasmic reticulum is modulated by FK506-binding protein. J. Biol. Chem. 268:1993;22992-22999.
350. Todd M. D., Grusby M. J., Lederer J. A., Lacy E., Lichtman A. H., Glimcher L. H. Transcription of the interleukin 4 gene is regulated by multiple promoter elements. J. Exp. Med. 177:1993;1663-1674.
351. Togashi H., Sasaki M., Frohman E., Taira E., Ratan R. R., Dawson T. M., Dawson V. L. Neuronal (type I) nitric oxide synthase regulates NFkB activity and immunologic (type II) nitric oxide synthase expression. Proc. Natl Acad. Sci. USA. 94:1997;2676-2680.
352. Tokime T., Nozaki K., Kikuchi H. Neuroprotective effect of FK506, an immunosuppressant, on transient global ischemia in gerbil. Neurosci. Lett. 206:1996;81-84.
353. Tomioka C., Nishioka K., Kogure K. Absence of early destructive changes of cytoskeletal proteins after transient ischemia in the rat. Brain Res. 586:1992;352-357.
354. Tong G., Shepherd D., Jahr C. E. Synaptic desensitization of NMDA receptors by calcineurin. Science. 267:1995;1510-1512.
355. Tsukahara T., Yonekawa Y., Tanaka K., Ohara O., Watanabe S., Kimura T., Nishijima T., Taniguchi T. The role of brain-derived neurotrophic factor in transient ischemia in the brain. Neurosurgery. 34:1994;323-331.
356. Tuma P. L., Stachniak M. C., Collins C. A. Activation of dynamin GTPase by acidic phospholipids and endogenous rat brain vesicles. J. Biol. Chem. 268:1993;17240-17246.
357. Uemura Y., Kowall N., Beal M. F. Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum. Ann. Neurol. 27:1990;620-625.
358. Van der Zee C. E. E. M., Nielander H. B., Vos J. P., Lopes da Silva S., Verhaagen J., Oestreicher A. B., Schrama L. H., Schotman P., Gispen W. H. Expression of growth-associated protein B-50 (GAP43) in dorsal root ganglia and sciatic nerve during regenerative sprouting. J. Neurosci. 9:1989;3505-3512.
359. Van Hooff C. O., De Graan P. N., Oestricher A. B., Gispen W. H. B-50 phosphorylation and polyphosphoinositide metabolism in nerve growth cone membranes. J. Neurosci. 8:1988;1789-1795.
360. Victor R. D., Thomas G. D., Marban E., O'Rourke B. Presynaptic modulation of cortical synaptic activity by calcineurin. Proc. Natl Acd. Sci. USA. 92:1995;6269-6273.
361. Volterra A., Trotti D., Cassutti P., Tromba C., Salvaggio A., Melcangi R. C., Racagni G. High sensitivity of glutamate uptake to extracellular free arachidonic acid levels in rat cortical synaptosomes and astrocytes. J. Neurochem. 59:1992;600-606.
362. Walaas S. I., Aswad D. W., Greengard P. A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. Nature. 301:1983;69-71.
363. Wallace R. W., Lynch T. J., Tallant E. A. An endogenous inhibitor protein of brain adenylate cyclase and cyclic nucleotide phosphodiesterase. Arch. Biochem. Biophys. 187:1978;328-334.
364. Wallace R. W., Lynch T. J., Tallant E. A., Cheung W. Y. Purification and characterization of an inhibitor protein of brain adenylate cyclase and cyclic nucleotide phosphodiesterase. J. Biol. Chem. 254:1979;377-382.
365. Wallace R. W., Tallant E. A., Cheung W. Y. High levels of a heat-labile calmodulin-binding protein (CaM-BP80) in bovine neostriatum. Biochemistry. 19:1980;1831-1837.
366. Wallis R. A., Panizzon K., Wasterman C. G. Inhibition of nitric oxide synthase protects against hypoxic neuronal injury. Neuroreport. 3:1992;645-648.
367. 2+- and protein modulator-activated cyclic nucleotide phosphodiesterase. Biochem. biophys. Res. Commun. 72:1976;926-932.
368. 2+-dependent association with the protein modulator of cyclic nucleotide phosphodiesterase. J. Biol. Chem. 252:1977;4175-4184.
369. 2+ signaling mechanisms in hippocampal CA1 neurons. J. Neurosci. 17:1997;4600-4611.
370. Wang J. K., Walaas S. I., Sihra T. S., Aderem A. A., Greengard P. Phosphorylation and associated translocation of 87-kDa protein, a major protein kinase C substrate, in isolated nerve terminals. Proc. Natl Acad. Sci. USA. 86:1989;2253-2256.
371. Wang T., Li B. T., Danielson P. D., Shah P. C., Rockwell S., Lechleider R. J., Martin J., Manganaro T., Donahoe P. The immunophilin FKBP12 functions as a common inhibitor of the TGFβ family type I receptors. Cell. 86:1996;435-444.
372. Wang X., Culotta V. C., Klee C. B. Superoxide dismutase protects calcineurin from inactivation. Nature. 383:1996;434-437.
373. Watson J. B., Sutcliffe J. G., Fisher R. S. Localization of the protein kinase C phosphorylation/calmodulin-binding substrate RC3 in dendritic spines of neostriatal neurons. Proc. Natl Acad. Sci. USA. 89:1992;8581-8585.
374. Wera S., Hemmings B. A. Serine/threonine protein phosphatases. Biochem. J. 311:1995;17-29.
375. 14C] Leucine incorporation into brain proteins in gerbils after transient ischemia. Relationship to selective vulnerability of hippocampus. J. Neurochem. 56:1991;789-796.
376. Winkler M. A., Merat D. L., Tallant E. A., Hawkins S., Cheung W. A. Catalytic site of calmodulin-dependent protein phosphatase from bovine brain resides in subunit A. Proc. Natl Acad. Sci. USA. 81:1984;3054-3058.
377. Wolff D. J., Sved D. W. The divalent cation dependence of bovine brain calmodulin-dependent phosphatase. J. Biol. Chem. 260:1985;4195-4202.
378. Wyllie A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-556.
379. Wyllie A. H., Kerr J. F. R., Currie A. R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:1980;251-306.
380. Xie Q. W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.
381. Yagita Y., Kitagawa K., Matsushita K., Taguchi A., Mabuchi T., Ohtsuki T., Yanagihara T., Matsumoto M. Effect of immunosuppressant FK506 on ischemia-induced degeneration of hippocampal neurons in gerbils. Life Sci. 59:1996;1643-1650.
382. 2+- and clamodulin-dependent phosphorylation of microtubule-associated protein 2 and tau factor, and inhibition of microtubule assembly. J. Neurochem. 41:1983;1119-1125.
383. 2+, calmodulin-dependent regulation of microtubule formation via phosphorylation of microtubule-associated protein 2, tau factor, and tubulin, and comparison with the cyclic AMP-dependent phosphorylation. J. Neurochem. 44:1985;759-768.
384. Yamamoto H., Fukunaga K., Lee K., Soderling T. R. Ischemia-induced loss of brain calcium/calmodulin-dependent protein kinase II. J. Neurochem. 58:1992;1110-1117.
385. Yamamoto K., Hayakawa T., Mogami H., Akai F., Yanagihara T. Ultrastructural investigation of the CA1 region of the hippocampus after transient cerebral ischemia in gerbils. Acta Neuropathol. 80:1990;487-492.
386. Yamasaki Y., Onodera H., Adachi K., Shozuhara H., Kogure K. Alteration in the immunoreactivity of calcineurin subunits after ischemic hippocampal damage. Neuroscience. 49:1992;545-556.
387. Yang G., Chan P. H., Chen J., Carlson E., Chen S. F., Weinstein P., Epstein C. J., Kamii H. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke. 25:1994;165-170.
388. Yang S. D., Tallant E. A., Cheung W. Y. Calcineurin is a calmodulin-dependent protein phosphatase. Biochem. biophys. Res. Commun. 106:1982;1419-1425.
389. Yokoyama N., Furuyama S., Wang J. H. Demonstration of calmodulin-stimulated phosphatase isozymes by monoclonal antibodies. J. Biol. Chem. 265:1990;8170-8175.
390. Yoshimi K., Takeda M., Nishimura T., Kudo T., Nakamura Y., Tada K., Iwata N. An immunohistochemical study of MAP2 and clathrin in gerbil hippocampus after cerebral ischemia. Brain Res. 560:1991;149-158.
391. Yoshino A., Hovda D. A., Katayama T., Becker D. P. Hippocampal CA3 lesion prevents the post concussive metabolic dysfunction in CA1. J. Cereb. Blood Flow Metab. 12:1992;996-1006.
392. Yun H. Y., Dawson V. L., Dawson T. M. Neurobiology of nitric oxide. Crit. Rev. Neurobiol. 10:1996;291-316.
393. Zauner A., Bullock R. The role of excitatory amino acids in severe brain trauma: opportunity for therapy: a review. J. Neurotrauma. 12:1995;547-554.
394. Zwiers, H., Oestreicher, A. B., Bisby, M. A., De Graan, P. N. E. and Gipsen, W. H. (1987) PKC substrate B-50 in adult and developing rat brain is identical to axonally-transported GAP43 in regenerating peripheral rat nerve. In: Axonal Transport, pp. 385-406. Eds. M. A. Bisby and R. S. Smith. Liss, New York.